Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cormedix Inc (NQ: CRMD )

9.500 -0.200 (-2.06%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 565,205
Open 9.790
Bid (Size) 9.460 (1)
Ask (Size) 10.00 (10)
Prev. Close 9.700
Today's Range 9.480 - 9.880
52wk Range 2.890 - 13.85
Shares Outstanding 38,086,437
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
CorMedix (CRMD) Q3 2024 Earnings Call Transcript
CRMD earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial

Performance

YTD
+151.99%
+151.99%
1 Month
-10.63%
-10.63%
3 Month
+69.64%
+69.64%
6 Month
+86.64%
+86.64%
1 Year
+166.85%
+166.85%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Biotech Momentum Trades For The Q4 Rally
Via Talk Markets
Earnings Preview For Cormedix
Via Benzinga
CRMD Stock Earnings: Cormedix Beats EPS for Q1 2024
Via InvestorPlace
Cormedix Earnings Preview
Via Benzinga
Why CorMedix Stock Popped Wednesday
Via Benzinga
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
Via Talk Markets
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
Via Benzinga
CorMedix (CRMD) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
CRMD Stock Earnings: Cormedix Meets EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Trading SMID Biotech Stocks In A Volatile Market
Via Talk Markets
CorMedix Inc. (NASDAQ: CRMD) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
CorMedix (CRMD) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
CorMedix (CRMD) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Earnings Scheduled For March 12, 2024
Via Benzinga
Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.